Research map: Gonadotropin-Releasing Hormone Agonists during Cyclophosphamide for Ovarian Protection in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

Back to the article

Papers in this map

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 106363 citations · Cited by this paper
  2. An early LH surge may jeopardize ART outcomes of patients with PCOS and its predictive models · 2026 · Related
  3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies · Erik B von Elm · 2007 · 17910 citations · Cited by this paper
  4. Response: Rectovaginal septum is a real location for deep endometriosis; comment on the article: ‘the myth of rectovaginal septum endometriosis’ · 2026 · Related
  5. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus · Antonis Fanouriakis · 2019 · 2052 citations · Cited by this paper
  6. Post-pregnancy contraception · 2026 · Related
  7. THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES · W. George Cochran · 1950 · 1331 citations · Cited by this paper
  8. Cognitive Stimulation Therapy in menopause: feasibility randomised controlled trial · 2026 · Related
  9. MOOSE Reporting Guidelines for Meta-analyses of Observational Studies · Benjamin S. Brooke · 2021 · 750 citations · Cited by this paper
  10. Therapeutic benefits of gonadotropins in male hypogonadotropic hypogonadism: a focus on spermatogenesis and fertility · 2026 · Related
  11. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient–Level Data · Matteo Lambertini · 2018 · 394 citations · Cited by this paper
  12. Higher BMI is associated with vaginal microbiome alterations in women with PCOS · 2026 · Related
  13. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases · Lisa R. Sammaritano · 2020 · 322 citations · Cited by this paper
  14. Unmet need for family planning among adolescent girls and young women (15–24 years) in Ethiopia during the FP2020 period: a propensity score matching analysis using PMA data · 2026 · Related
  15. The development methods of official GRADE articles and requirements for claiming the use of GRADE – A statement by the GRADE guidance group · Holger Jens Schünemann · 2023 · 275 citations · Cited by this paper
  16. The maternal immune response to semen: implications for reproductive success in livestock · 2026 · Related
  17. Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus · Emily C. Somers · 2005 · 269 citations · Cited by this paper
  18. Rapamycin co-exposure fails to reduce cisplatin-induced damage in GC6-spg spermatogonial cell line · 2026 · Related
  19. Fertility Preservation in People With Cancer: ASCO Guideline Update · Hui-Chun Irene Su · 2025 · 265 citations · Cited by this paper
  20. Pathogenic homozygous PLCZ1 mutation reduces sperm protein levels with a simulated reduction of PIP2 binding: a case report · 2026 · Related
  21. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy · Chi Chiu Mok · 1998 · 246 citations · Cited by this paper
  22. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy · Zeev Blumenfeld · 2000 · 192 citations · Cited by this paper
  23. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study · Karin Manger · 2005 · 123 citations · Cited by this paper
  24. Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) is Improving: Results from a Case Control Study and Literature Review · Sai Yan Yuen · 2008 · 117 citations · Cited by this paper
  25. Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230 · Halle C. F. Moore · 2018 · 92 citations · Cited by this paper
  26. Gonadotropin Releasing Hormone Agonists May Minimize Cyclophosphamide Associated Gonadotoxicity in SLE and Autoimmune Diseases · Zeev Blumenfeld · 2011 · 50 citations · Cited by this paper
  27. Safety of GnRH agonists and antagonists · Basil C. Tarlatzis · 2004 · 34 citations · Cited by this paper
  28. Effect of a gonadotropin‐releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study · Tomohiro Koga · 2018 · 26 citations · Cited by this paper
  29. Fertility and Pregnancy in Systemic Lupus Erythematosus · Alexis Jones · 2016 · 9 citations · Cited by this paper
  30. SAT0260 Ovarian function preservation with gonadotropin-releasing hormone analogues in patients with systemic lupus erythematosus treated with cyclophosphamide · VA Pacucci · 2017 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)